Treatment and prevention of vitamin D deficiency from the perspective of personalized medicine


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The problem of maintaining health, increasing life expectancy, and reducing the level of chronic diseases continues to be one of the priorities in medicine. Changes in the lifestyle and nutrition of a modern person are reflected in his health. The situation can often be associated with a deficiency of a number of micronutrients, among which vitamin D is of the greatest importance; its deficiency has been proven to impair the function of many organs and systems, contributing to the development and progression of chronic diseases over time. The article considers the biochemical aspects of vitamin D, presents an analysis of indications for the exclusion of this pathology, a personalized approach to the treatment of such patients and the need for maintenance therapy after normalization of vitamin D level. A comparative review of medicines and biologically active dietary supplements containing vitamin D, taking into account the modern regulatory framework, was carried out.

Full Text

Restricted Access

About the authors

Tatyana V. Tazina

Ryazan State Medical University n.a. Academician I.P. Pavlov

Email: tazina@inbox.ru
Cand. Sci. (Med.), Associate Professor at the, Department of Surgery, Obstetrics and Gynecology FAPE Ryazan, Russia

T. N Bebneva

Peoples' Friendship University of Russia; National Medical Research Center of Endocrinology

References

  1. Николаев А.Я. Биологическая химия. 3-е изд., перераб. и доп. М., 2004. 566 с.
  2. Строев Е.А. Биологическая химия: Учебник для фармацевтических институтов и фармацевтических факультетов мед. институтов. М., 1986. 479 с.
  3. Громова О.А., Торшин И.Ю., Спиричев В.Б. Полногеномный анализ сайтов связывания рецептора витамина d указывает на широкий спектр потенциальных применений витамина D в терапии. Медицинский совет 2016;1:12-21.
  4. Haghsheno M.A., Mellstrom D., Behre C.J., et al. Low 25-OH vitamin D is associated with benign prostatic hyperplasia. J Urol. 2013;190(2):608-14. doi: 10.1016/j.juro.2013.01.104.
  5. Xu Y, Shao X., Yao Y, et al. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated metaanalysis. J Cancer Res Clin Oncol. 2014;140(9):1465-77. doi: 10.1007/s00432-014-1706-3.
  6. Xu Y, He B., Pan Y, et al. Systematic review and metaanalysis on vitamin D receptor polymorphisms and cancer risk. Tumour Biol. 2014;35(5):4153-69. doi: 10.1007/s13277-013-1544-y.
  7. World Health Organization (WHO) [Electronic resource]. URL: https://www.who.int/ru/news-room/fact-sheets/detail/the-top 10-causes-of-death
  8. Yin K., Agrawal D.K. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69-87. Doi: 10.2147/ JIR.S63898.
  9. Carbone F., et al. Potential pathophysiological role for the vitamin D deficiency in essential hypertension. World J Cardiol. 2014;6(5):260-76. Doi: 10.4330/ wjc.v6.i5.260.
  10. Forman J.P, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013;61(4):779-85. Doi: 10.1161/ HYPERTENSIONAHA.111.00659.
  11. Abd-Allah S.H., Pasha H.F., Hagrass H.A., Alghobashy A.A. Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Gene. 2014;536(2):430-34. doi: 10.1016/j.gene.2013.12.032.
  12. Dutta D., Maisnam I., Shrivastava A., et al. Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res. 2013;138(6): 853-60.
  13. Al-Daghri N.M., Sabico S., Al-Saleh Y, et al. Calculated adiposity and lipid indices in healthy Arab children as influenced by vitamin D status. J Clin Lipidol. 2016;10:775-81. doi: 10.1016/j.jacl.2016.02.005.
  14. Hejazian S.M., Ahmadian E., Vahed S.Z., et al. The Association of Sleep Quality and Vitamin D Levels in Hemodialysis Patients. BioMed Res Intern. 2021(1):1-7. doi: 10.1155/2021/4612091.
  15. Баева Е.А. Рынок пищевых ингредиентов: современные тренды и ориентиры развития. Пищевые ингредиенты и добавки. 2013;2:55-7.
  16. Monteiro J.P, Wise C., et al. Methylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin Study. Gen Nutrit. 2014;9(3):403. doi: 10.1007/s12263-014-0403-9.
  17. Matsuoka L.Y, et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64(6):1165-68. doi: 10.1210/jcem-64-6-1165.
  18. Wacker M., Holick M.F. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol. 2013;5(1):51-108. doi: 10.4161/derm.24494.
  19. Clemens T.L., et al. Increased Skin Pigment Reduces the Capacity of Skin To Synthesise Vitamin D3. Lancet. 1982;319(8263):74-6. doi: 10.1016/s0140-6736(82)90214-8.
  20. Webb A.R., Kline L., Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67(2):373-78. doi: 10.1210/jcem-67-2-373.
  21. Chen T.C., et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 200-;460(2):213-10.Doi: 10.1016/j. abb.2006.12.017.
  22. Pereira-Santos M., et al. Obesity and vitamin D deficiency: A systematic review and metaanalysis. Obes Rev. 2015;16(4):341-49. doi: 10.1111/obr.12239.
  23. Nuti R., et al. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med. 2001;250(4):361-66. doi: 10.1046/j.1365-2796.2001.00895.x.
  24. Gilman J., Shanahan F., Cashman K.D. Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr. 2006;60(7):889-96. Doi: 10.1038/ sj.ejcn.1602395.
  25. Chakhtoura M., et al. Hypovitaminosis D in Bariatric Surgery: A Systematic Review of Observational Studies. Metab. 2316;65(4):574-85. Doi: 10.1016/j. metabol.2015.12.004.
  26. Aasheim E.T, Bjorkman S., Sovik T.T. Vitamin status after bariatric surgery: A randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2010;91(1):15-doi: 10.3945/ajcn.2009.27583.
  27. Schmidt-Gayk H., et al. 25-Hydroxy-Vitamin-D in Nephrotic Syndrome. Lancet. doi: 10.1016/s0140-6736(77)90118-0.
  28. Stokes C.S., et al. Vitamin D in chronic liver disease. Liver Int. 2013;33(3):338-52. doi: 10.1111/liv.12106.
  29. Karakelides H., et al. Vitamin D-mediated hypercalcemia in slack skin disease: Evidence for involvement of extrarenal 25-hydroxyvitamin D 1a-hydroxylase. J Bone Miner Res. 2006;21(9):1496-99. Doi: 10.1359/ jbmr.060608.
  30. Grey A., et al. Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D Insufficiency. JCEM. 2015;90:2122-26. Doi: 10.1210/ jc.2004-1772.
  31. Robien K., et al. Drug-Vitamin D Interactions: A Systematic Review of the Literature. Nutr Clin Pract. 2313;28(2):194-238. doi: 10.1177/0884533612467824.
  32. Дефицит витамина D у взрослых: диагностика, лечение и профилактика. Клинические рекомендации. М., 2015.
  33. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press, 2311.
  34. Holick M.F., et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2311;96(7):1911-33. doi: 13.1213/jc.2311-3385.
  35. Giustina A., et al. Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus. 2020;4(12):1-13. doi: 13.1332/jbm4.13417.
  36. Bouillon R., et al. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr Rev. 2019;40(4):1109-51. doi: 10.1210/er.2018-00126.
  37. Bouillon R., et al. Optimal vitamin D status: A critical analysis on the basis of evidencebased medicine. J Clin Endocrinol Metab. 2313;98(8):E1283-334. doi: 10.1210/jc.2013-1195.
  38. Manson J.A.E., Bassuk S.S., Buring J.E. Principal results of the VITamin D and OmegA3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J Steroid Biochem Mol Biol. 2020;198:105522. doi: 10.1016/j.jsbmb.2019.105522
  39. Scragg R. The Vitamin D Assessment (ViDA) study -Design and main findings. J Steroid Biochem Mol Biol. 2020;198:105562. Doi: 10.1016/j. jsbmb.2019.105562.
  40. Рожинская Л.Я. и др. Применение высокодо-зных препаратов колекальциферола для лечения дефицита витамина D: результаты открытого многоцентрового сравнительного рандомизированного исследования. Остеопороз и остеопатии. 2321;23(3):4-16
  41. Мельниченко Г.А., Намазова-БарановаЛ.С., Громова О.А. и др. Профилактика и лечение дефицита витамина D: выбор оптимального подхода. Вопросы современной педиатрии. 2021;20(4):338-45
  42. Нормативно-правовая база КонсультантПлюс. URL: http://www.consultant.ru
  43. Hollander D., Truscott T.C. Mechanism and site of small intestinal uptake of vitamin D3 in pharmacological concentrations. Am J Clin Nutr. 1976;29(9):973-75. doi: 10.1093/ajcn/29.9.970.
  44. Lenormand Y., Rautureau M., Mary J.Y, Rambaud J.C. Intestinal absorption of vitamin D, linoleic acid and cholesterol from micellar solutions: study in normal humans by the «in situ» perfusion method. Biol Gastroenterol (Paris). 1975;8(3):207-21.
  45. Шохин И.Е., Малашенко Е.А., Медведев Ю.В. и др. Разработка, валидация и применение методики количественного определения витамина D3 (холекальциферола) методом ВЭЖХ с УФ-детектированием для анализа лекарственных средств и биологически активных добавок к пище. Разработка и регистрация лекарственных средств. 2021;10(2):87-99.
  46. Житникова Л.М. Аквадетрим® - профилактика рахита и ОРВИ у часто болеющих детей. Практика педиатра. 2311;2:63-2.
  47. Романцова Е.Б., Бабцева А.Ф., Борисенко Е.П. и др. D-дефицитное состояние у часто болеющих детей в Амурской области. Практичеcкая медицина. 2317;5(136):53-5.
  48. E.B., Babtseva A.F., Borisenko E.P, et al. D-deficiency condition in frequently ill children in the Amur region. Prakticheskaya Meditsina. 2017;5(106):53-5. (In Russ.)].
  49. Громова О.А., Пронин А.В., Гришина Т.Р и др. Противоопухолевые эффекты Аквадетрима водного раствора мицелл с витамином D. Фарматека. 2315;23(313):63-68.
  50. Мальцева, Л.И., Васильева Э.Н., Денисова Т.Г. Значение дефицита витамина D для развития тяжелых форм преэклампсии у женщин группы высокого риска. Акушерство и гинекология. 2018;9:120-25.
  51. Татарова Н.А., Айрапетян М.С. Дефицит витамина D и железодефицитная анемия у женщин в переходном менопаузальном периоде. Клинический случай. Гинекология. 2020;22(5):87-90.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies